15 | oleandrinIBA
01/2022
-
01/2006 |
14 | Pharmaceutical PreparationsIBA
01/2022
-
05/2002 |
14 | Cyclooxygenase 2 (Cyclooxygenase-2)IBA
04/2009
-
11/2002 |
13 | Cardiac GlycosidesIBA
01/2022
-
01/2006 |
12 | Proteins (Proteins, Gene)FDA Link
12/2016
-
05/2002 |
11 | Dinoprostone (PGE2)FDA Link
07/2014
-
12/2002 |
11 | EnzymesIBA
07/2014
-
08/2002 |
11 | Arachidonic Acid (Vitamin F)IBA
10/2012
-
09/2002 |
10 | Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
10/2012
-
09/2002 |
10 | ProstaglandinsIBA
06/2009
-
09/2002 |
9 | PBI-05204IBA
01/2022
-
11/2011 |
8 | LipidsIBA
08/2009
-
03/2003 |
7 | Celecoxib (Celebrex)FDA Link
02/2010
-
09/2004 |
7 | Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
06/2009
-
11/2002 |
6 | Protein Isoforms (Isoforms)IBA
04/2014
-
01/2008 |
6 | EicosanoidsIBA
05/2008
-
09/2004 |
5 | Antiviral Agents (Antivirals)IBA
01/2022
-
01/2016 |
5 | Leukotriene B4IBA
07/2010
-
09/2006 |
5 | Lipoxygenase (Lipoxygenase-1)IBA
07/2010
-
09/2002 |
5 | Prostaglandins EIBA
06/2009
-
09/2002 |
4 | Adenosine Triphosphatases (ATPase)IBA
04/2014
-
01/2008 |
4 | Messenger RNA (mRNA)IBA
10/2012
-
09/2003 |
4 | ZyflamendIBA
01/2011
-
01/2007 |
4 | CurcuminIBA
11/2009
-
10/2005 |
4 | NF-kappa B (NF-kB)IBA
09/2009
-
10/2005 |
4 | 15-hydroxyprostaglandin dehydrogenaseIBA
06/2009
-
08/2006 |
4 | Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA
04/2009
-
09/2006 |
4 | anthraceneIBA
11/2008
-
09/2006 |
4 | Hydroxyeicosatetraenoic Acids (HETE)IBA
10/2007
-
02/2005 |
3 | Fish OilsIBA
07/2014
-
06/2004 |
3 | AcidsIBA
07/2010
-
05/2002 |
3 | AzoxymethaneIBA
06/2009
-
08/2006 |
3 | Fatty Acids (Saturated Fatty Acids)IBA
01/2009
-
06/2003 |
3 | PPAR gammaIBA
01/2009
-
03/2005 |
3 | Biological ProductsIBA
07/2008
-
05/2002 |
3 | Cisplatin (Platino)FDA LinkGeneric
09/2004
-
05/2002 |
2 | VaccinesIBA
06/2021
-
07/2020 |
2 | CytokinesIBA
01/2015
-
07/2008 |
2 | Eicosapentaenoic AcidIBA
07/2014
-
06/2004 |
2 | prostaglandin E3 (PGE3)IBA
07/2014
-
05/2008 |
2 | 12-Hydroxy-5,8,10,14-eicosatetraenoic AcidIBA
10/2012
-
10/2007 |
2 | LipoxygenasesIBA
10/2012
-
09/2004 |
2 | Anti-Inflammatory Agents (Anti-Inflammatories)IBA
01/2011
-
11/2009 |
2 | 13-hydroxy-9,11-octadecadienoic acidIBA
07/2010
-
10/2007 |
2 | 7- hydroxy- 5,11- dioxotetranorprostane- 1,16- dioic acidIBA
04/2009
-
06/2006 |
2 | AntioxidantsIBA
09/2008
-
08/2007 |
2 | ErbB Receptors (EGF Receptor)IBA
07/2008
-
12/2004 |
2 | Phosphotransferases (Kinase)IBA
07/2008
-
01/2007 |
2 | Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
05/2008
-
05/2008 |
2 | 5-hydroxy-6,8,11,14-eicosatetraenoic acidIBA
10/2007
-
01/2005 |
2 | 15-hydroxy-5,8,11,13-eicosatetraenoic acidIBA
10/2007
-
01/2005 |
2 | LeukotrienesIBA
10/2007
-
12/2006 |
2 | Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
08/2007
-
01/2006 |
2 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2006
-
09/2003 |
2 | Paclitaxel (Taxol)FDA LinkGeneric
10/2005
-
11/2002 |
2 | Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA
05/2005
-
07/2003 |
2 | aseanostatin P5IBA
01/2005
-
06/2003 |
2 | Caspase 3 (Caspase-3)IBA
01/2005
-
06/2003 |
2 | SolutionsIBA
09/2004
-
09/2003 |
2 | Phosphates (Orthophosphate)IBA
09/2003
-
03/2003 |
2 | lysophosphatidic acidIBA
09/2003
-
03/2003 |
1 | 3-(2'-pyridyldithio)benzyldiazoacetate (MPDA)IBA
10/2020 |